East Windsor, NJ - The FDA has given i-STAT Corporation clearance to market its prothrombin time (PT) test for use with the company's portable clinical analyzer according to a company press release.

THE increasing enthusiasm for treating thromboembolic diseases with prothrombin-reducing drugs for long periods in ambulatory patients has emphasized the lack of clear definition of the therapeutic ...

This is a preview. Log in through your library . Vision – To be the world's leading and most trusted provider of information and services that will make a real difference in clinical practice and ...

AS A result of the widespread use of dicumarol in the prevention and treatment of thromboembolism, clinicians have become increasingly interested in the role of prothrombin in blood coagulation.

INDIANAPOLIS, March 19 /PRNewswire/ -- Medicare Part B will now cover and pay for meter training, equipment and supplies for all long-term warfarin users who monitor their prothrombin time at home ...